TY  - CHAP
M1  - Book, Section
TI  - The Evaluation of the Infertile Man
A1  - Ghayda, Ramy Abou
A1  - Bhasin, Shalender
A1  - Kathrins, Martin
A2  - Bhasin, Shalender
A2  - O’Leary, Michael P.
A2  - Basaria, Shehzad S.
PY  - 2021
T2  - Essentials of Men’s Health
AB  - The  American  Society  of  Reproductive  Medicine  (ASRM)  and  the  World  Health  Organization  (WHO)  define  infertility  as  a  disease  rather  than  a  condition.1,2  It  is  defined  as  the  inability  to  conceive  and  establish  a  clinical  pregnancy  after  12  months  (among  women  less  than  35  years  of  age)  or  more  of  regular,  timed,  and  unprotected  sexual  intercourse.3  The  prevalence  of  infertility  is  estimated  to  be  1  in  every  7  couples  in  the  developed  countries  and  1  in  4  couples  in  the  developing  countries.  Overall  infertility  is  estimated  to  affect  8%  to  12%  of  couples  in  their  reproductive  years  globally.4  Male  factors  are  contributory  in  50%  of  infertile  couples  and  are  the  sole  culprit  in  20%  to  30%.5  Evaluation  of  the  infertile  man  often  requires  a  multifaceted  approach  to  identify  underlying  pathologies,  which  may  be  correctable  (Table  14-1).  The  evaluation  approach  described  here  is  designed  to  facilitate  the  recognition  of  treatable  conditions  such  as  gonadotropin  deficiency,  obstruction,  and  coital  disorders;  identification  of  those  who  are  candidates  for  corrective  surgery  or  assisted  reproductive  technologies  (ARTs);  those  who  are  sterile  and  should  consider  adoption  or  artificial  insemination  using  donor  sperm;  and  those  who  should  undergo  genetic  screening  and  appropriate  genetic  counseling  (Table  14-3).  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1174515863
ER  -